Assignee
ALAR PHARMACEUTICALS INC
TW·5 granted patents·1 pending application·3 citations·filing 2017–2023
Top patents by PatentIndex Score
6 records- 0172US11524965B2Long-acting injectable formulations and crystalline forms of buprenorphine derivativesALAR PHARMACEUTICALS INC·Filed 2019·Granted Dec 13, 2022·1 cites·8 claims
- 0266US10744132B2Sustained-release buprenorphine formulationsALAR PHARMACEUTICALS INC·Filed 2017·Granted Aug 18, 2020·2 cites·7 claims
- 0358US12522610B2Long-acting injectable formulations and crystalline forms of buprenorphine derivativesALAR PHARMACEUTICALS INC·Filed 2022·Granted Jan 13, 2026·0 cites·15 claims
- 0457US2026000667A1Stable pharmaceutical composition of buprenorphine and preparation method and use thereofALAR PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0555US11981617B2Ketamine pamoate and use thereofALAR PHARMACEUTICALS INC·Filed 2020·Granted May 14, 2024·0 cites·13 claims
- 0637US12201630B2Naltrexone injectable sustained release formulationALAR PHARMACEUTICALS INC·Filed 2019·Granted Jan 21, 2025·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when ALAR PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →